Home > PS Ratio > GLAND PHARMA

GLAND PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of GLAND PHARMA is 5.11.

Share Price ₹1,825.5Dec 26,2024
Market Cap ₹30,084.2 Cr
Sales-TTM₹5,890.2 CrTTM-Consolidated Results
Price/Sales5.11xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of GLAND PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GLAND PHARMA is calculated as :

Current Market Cap [ ₹30,084.2 Cr] as on Dec 26,2024

(/) Sales [ ₹5,890.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.11x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GLAND PHARMA , the investors are currently willing to pay '5.11 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GLAND PHARMA !

The chart below summarizes the trend in P/S Ratio of GLAND PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of GLAND PHARMA


PS Ratio Performance Analysis for GLAND PHARMA

- GLAND PHARMA 's latest p/e ratio is 5.11x.

- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.01x.

- GLAND PHARMA 's operated at median p/e ratio of 5.76x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 12.21x.

- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.


How does GLAND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GLAND PHARMA 5,890.25.1130,084.2
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.78441,838.0
CIPLA LTD26,512.04.54120,270.0
DR REDDYS LABORATORIES LTD30,084.93.76113,077.0
ZYDUS LIFESCIENCES LTD21,483.54.4996,553.2
DIVIS LABORATORIES LTD8,614.018.12156,107.0
MANKIND PHARMA LTD11,018.010.91120,212.0
TORRENT PHARMACEUTICALS LTD11,225.010.30115,643.0
LUPIN LTD21,431.34.6499,532.1
AUROBINDO PHARMA LTD30,295.02.4172,945.8
ABBOTT INDIA LTD6,066.110.0360,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAND PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.41x
Max industry PS 18.12x
Median industry PS 5.11x
Average industry PS 7.55x



You may also like the below Video Courses